TABLE 3.
Strain and dose | No. of cultures positive/no. tested
|
No. of mice infected/no. tested | ||||||
---|---|---|---|---|---|---|---|---|
Skin | Spleen | Joint | Lymph node | Heart | Bladder | All sites | ||
MSK5 | ||||||||
103 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
ML23 | ||||||||
103 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/18 | 0/3 |
105 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/18 | 0/3 |
wt (ML23/pBBE22) | ||||||||
102 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
103 | 2/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 17/18 | 3/3 |
104 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
105 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
mt (MM4/pBBE22) | ||||||||
102 | 0/3 | 2/3 | 2/3 | 2/3 | 2/3 | 2/3 | 10/18 | 2/3 |
103 | 3/3 | 2/3 | 3/3 | 3/3 | 3/3 | 3/3 | 17/18 | 3/3 |
104 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
105 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
ct (MM4/pBBE22-bba64+) | ||||||||
102 | 3/3 | 2/3 | 3/3 | 3/3 | 2/3 | 3/3 | 16/18 | 3/3 |
103 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |
104 | 2/3 | 2/3 | 2/3 | 2/3 | 2/3 | 2/3 | 12/18 | 2/3 |
105 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 18/18 | 3/3 |